» Articles » PMID: 21330454

Sarcoidosis-related Mortality in the United States from 1988 to 2007

Overview
Specialty Critical Care
Date 2011 Feb 19
PMID 21330454
Citations 117
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: It has been nearly 20 years since sarcoidosis mortality was examined at the population level in the United States.

Objectives: To examine mortality rates and underlying causes of death among United States decedents with sarcoidosis from 1988-2007.

Methods: We used data from the National Center for Health Statistics to (1) calculate age-adjusted sarcoidosis-associated mortality rates; (2) examine how those rates differ by age, sex, and race and ethnicity; and (3) determine underlying causes of death among sarcoidosis decedents.

Measurements And Main Results: From 1988-2007, there were 46,450,489 deaths in the United States and 23,679 decedents with sarcoidosis mentioned on their death certificates. Over this time, the age-adjusted, sarcoidosis-related mortality rate increased 50.5% in women and 30.1% in men. The greatest absolute increase in death rates was among non-Hispanic black females. Regardless of sex or race, mortality rates climbed most in decedents 55 years or older. The most common cause of death was sarcoidosis itself. Younger sarcoidosis decedents with pulmonary fibrosis were more likely to be black than white, and younger sarcoidosis decedents were more likely than similarly aged decedents in the general population to have a cardiac cause contribute to death.

Conclusions: From 1988-2007, sarcoidosis-related mortality rates increased significantly, particularly in non-Hispanic black females aged 55 years or older. The underlying cause of death in most patients with sarcoidosis was the disease itself. Among young sarcoidosis decedents, those with pulmonary fibrosis or a cardiac cause contributing to death were more likely to be black than white.

Citing Articles

Detection of Myocardial Deformation Patterns and Prognostic Value of Routine Echocardiographic Parameters in Patients with Cardiac Sarcoidosis Versus Extracardiac Sarcoidosis: Systematic Review and Meta-Analysis.

Jain H, Shahzad M, Usman M, Kc A, Singh J, Jain J Diagnostics (Basel). 2025; 15(5).

PMID: 40075765 PMC: 11898684. DOI: 10.3390/diagnostics15050518.


Phenotypes and Endotypes in Sarcoidosis: Unraveling Prognosis and Disease Course.

Papanikolaou I, Chytopoulos K, Kaitatzis D, Kostakis N, Bogiatzis A, Steiropoulos P Biomedicines. 2025; 13(2).

PMID: 40002701 PMC: 11853411. DOI: 10.3390/biomedicines13020287.


Shifting temporal trends and disparities in sarcoidosis mortality in the United States: A retrospective analysis from 1999 to 2020.

Raza F, Kumar S, Mohammad A, Amin A, Ahmad F, Tousif S PLoS One. 2025; 20(1):e0317237.

PMID: 39792876 PMC: 11723600. DOI: 10.1371/journal.pone.0317237.


Nationwide Cross-Sectional Analysis of Mortality Trends in Patients with Sarcoidosis and Non-Ischemic Cardiovascular Disease-The Impact of Gender, Ethnicity, Geographical Location, and COVID-19 Pandemic.

Ahmed R, Ahmed M, Khlidj Y, Rehman O, Al-Mukhtar L, Abou Khater N J Clin Med. 2024; 13(23).

PMID: 39685921 PMC: 11642065. DOI: 10.3390/jcm13237463.


Elevated Mortality Risk in the First Year Post-Diagnosis of Sarcoidosis: A Comprehensive Population-Based Cohort Study.

Patt Y, Sharif K, David P, Hen O, Gendelman O, Elizur Y Medicina (Kaunas). 2024; 60(11).

PMID: 39596972 PMC: 11596794. DOI: 10.3390/medicina60111787.


References
1.
Rybicki B, Major M, Popovich Jr J, Maliarik M, Iannuzzi M . Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997; 145(3):234-41. DOI: 10.1093/oxfordjournals.aje.a009096. View

2.
Bramer G . International statistical classification of diseases and related health problems. Tenth revision. World Health Stat Q. 1988; 41(1):32-6. View

3.
Yamaguchi M, Hosoda Y, Sasaki R, Aoki K . Epidemiological study on sarcoidosis in Japan. Recent trends in incidence and prevalence rates and changes in epidemiological features. Sarcoidosis. 1989; 6(2):138-46. View

4.
Olson A, Swigris J, Lezotte D, Norris J, Wilson C, Brown K . Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med. 2007; 176(3):277-84. DOI: 10.1164/rccm.200701-044OC. View

5.
Redelings M, Sorvillo F, Simon P . A comparison of underlying cause and multiple causes of death: US vital statistics, 2000-2001. Epidemiology. 2005; 17(1):100-3. DOI: 10.1097/01.ede.0000187177.96138.c6. View